Opportunity Information: Apply for 720656 RFI TBCONTROL
The Mozambique Local Tuberculosis Response II opportunity is a USAID/Mozambique health-focused funding initiative connected to the Government of the Republic of Mozambique's national efforts to reduce the burden of tuberculosis (TB), including drug-resistant TB (DR-TB), in selected provinces. It is framed as a continuation activity and is positioned to strengthen and extend ongoing TB control work rather than start an entirely new standalone program. The opportunity is being managed through USAID/Mozambique's Integrated Health Office (IHO), which suggests it is meant to fit into broader health system priorities and coordination with government-led service delivery structures, rather than operate in isolation.
At its core, this notice is an RFI (Request for Information) tied to the preparation of a program description, meaning USAID is gathering input from stakeholders and potential partners to refine what the activity should look like, what approaches are likely to be most effective, and how implementation should be structured to best support national TB and DR-TB goals. The emphasis on improving the "Program Description" indicates that USAID is in a planning and design phase, seeking practical insights on technical strategies, operational considerations, and potentially the realities on the ground in the target provinces. While the notice itself does not spell out specific interventions, the stated objective clearly centers on reducing TB incidence and impact, with explicit attention to drug resistance, which typically requires more complex diagnostics, stronger treatment adherence support, and closer patient monitoring.
The funding instrument type listed is a Cooperative Agreement, which generally implies substantial involvement by USAID during implementation. In practice, that often means the selected recipient would not only carry out agreed activities but also work closely with USAID on planning, monitoring, problem-solving, and adjustments over time. The activity category is Health, and the CFDA (assistance listing) number provided is 98.001, associated with USAID foreign assistance programming. Eligibility is listed as unrestricted, meaning USAID is not limiting the pool to a narrow class of organizations in this posting, which can open the door to a range of applicants such as NGOs, local organizations, international implementers, academic institutions, and others, depending on final solicitation requirements.
Several posted fields signal that this is informational and pre-award in nature. The Award Ceiling is shown as 0, and the Expected Awards field is blank, which typically indicates that USAID is not yet declaring a budget range or the anticipated number of awards at this stage. Instead, the key immediate action is responding to the RFI by the stated deadline, with the intent of shaping the eventual activity design and future competitive or continuation process. The Funding Opportunity Number is listed as 720656 RFI TBCONTROL, and the title is Mozambique Local Tuberculosis Response II, indicating it is part of a structured TB control portfolio and likely follows an earlier phase or related predecessor programming.
Administratively, the opportunity is issued by USAID-Maputo (USAID/Mozambique). The creation date is November 22, 2022, and the original closing date is December 20, 2022. Taken together, the notice communicates that USAID/Mozambique is actively planning the next iteration of TB support programming, with an emphasis on aligning assistance to the Government of Mozambique's TB and DR-TB priorities in selected provinces, and that it is using the RFI process to gather technical and operational input before finalizing a program description and moving toward an award under a cooperative agreement mechanism.Apply for 720656 RFI TBCONTROL
- The Mozambique USAID-Maputo in the health sector is offering a public funding opportunity titled "Mozambique Local Tuberculosis Response II" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
- This funding opportunity was created on 2022-11-22.
- Applicants must submit their applications by 2022-12-20. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Unrestricted.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: Mozambique USAID-Maputo
Browse more opportunities from the same category: Health
Next opportunity: Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional)
Previous opportunity: Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for 720656 RFI TBCONTROL
Applicants also applied for:
Applicants who have applied for this opportunity (720656 RFI TBCONTROL) also looked into and applied for these:
| Funding Opportunity |
|---|
| Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required) Apply for PAR 22 256 Funding Number: PAR 22 256 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) Apply for PAR 23 065 Funding Number: PAR 23 065 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) Apply for RFA RM 23 003 Funding Number: RFA RM 23 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Optional) Apply for RFA OD 23 002 Funding Number: RFA OD 23 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) Apply for PAR 23 036 Funding Number: PAR 23 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) Apply for PAR 23 057 Funding Number: PAR 23 057 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Optional) Apply for RFA OD 23 005 Funding Number: RFA OD 23 005 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R61/R33 Clinical Trial Required) Apply for PAR 23 043 Funding Number: PAR 23 043 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional) Apply for RFA AT 23 008 Funding Number: RFA AT 23 008 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Interorgan Communication in Aging (U01 Clinical Trial Not Allowed) Apply for RFA AG 24 005 Funding Number: RFA AG 24 005 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Clinical Studies of Mental Illness (Collaborative R01) (Clinical Trial Optional) Apply for PAR 23 050 Funding Number: PAR 23 050 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories (UC7 Clinical Trial Not Allowed) Apply for RFA AI 22 075 Funding Number: RFA AI 22 075 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| NIH StrokeNet- Regional Coordinating Stroke Centers for year 2023 (U24 - Clinical Trials Not Allowed) Apply for RFA NS 23 010 Funding Number: RFA NS 23 010 Agency: National Institutes of Health Category: Health Funding Amount: $1,750,000 |
| NIH StrokeNet National Coordinating Center for year 2023 (U01 Clinical Trials Not Allowed) Apply for RFA NS 23 009 Funding Number: RFA NS 23 009 Agency: National Institutes of Health Category: Health Funding Amount: $1,750,000 |
| NIH StrokeNet National Data Management Center for year 2023 (U01 Clinical Trials Not Allowed) Apply for RFA NS 23 008 Funding Number: RFA NS 23 008 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional) Apply for RFA AT 23 009 Funding Number: RFA AT 23 009 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional) Apply for PAR 23 063 Funding Number: PAR 23 063 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Biomedical Research Facilities (C06 Clinical Trial Not Allowed) Apply for PAR 23 045 Funding Number: PAR 23 045 Agency: National Institutes of Health Category: Health Funding Amount: $8,000,000 |
| Autoimmunity Centers of Excellence, Basic Research Program (U19 Clinical Trial Not Allowed) Apply for RFA AI 22 070 Funding Number: RFA AI 22 070 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Autoimmunity Centers of Excellence, Clinical Research Program (UM1 Clinical Trial Required) Apply for RFA AI 22 071 Funding Number: RFA AI 22 071 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "720656 RFI TBCONTROL", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.